WST · 10-Q · 2026Q3 · Full report
Share Repurchase Program
WEST PHARMACEUTICAL SERVICES INC · 2026-10-29 · Importance 33 · Surprise 42 · In source text
West repurchased 2,424,121 shares of common stock during the nine months ended September 30, 2026, for $685.3 million, at an average price of $282.68 per share. The company identified share repurchases as a primary reason cash and cash equivalents declined during the period. Cash and cash equivalents fell to $464.1 million at September 30, 2026, from $791.3 million at December 31, 2025.
Key facts
- WEST PHARMACEUTICAL SERVICES INC repurchased 2,424,121 common shares during the nine months ended September 30, 2026, at a cost of $685.3 million and an average price of $282.68 per share. source
- WEST PHARMACEUTICAL SERVICES INC’s net cash used in financing activities increased $541.9 million for the nine months ended September 30, 2026, primarily because of increased share repurchases. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | realized | -16.9% | WEST PHARMACEUTICAL SERVICES INC repurchased 2,424,121 common shares during the nine months ended September 30, 2026, at a cost of $685.3… |
| cash | negative | realized | -13.3% | WEST PHARMACEUTICAL SERVICES INC’s net cash used in financing activities increased $541.9 million for the nine months ended September 30,… |